Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc DGNOF


Primary Symbol: V.ADK

Healthcare Medical Devices
DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS Welcomes Mr. Vincent Duhamel and Mr. Robert J. Dunn to its Board of Directors

GlobeNewswire September 28, 2020

DIAGNOS Announces a Multi-Year Contract with Chaparral Medical Group in California

GlobeNewswire September 15, 2020

DIAGNOS Receives $2,000,000 Assistance from Quebec

GlobeNewswire September 8, 2020

DIAGNOS Announces Annual General Meeting of Shareholders Date and Attendance Special Measures

GlobeNewswire August 26, 2020

DIAGNOS Announces Signing of Service Agreement with the Colombian Telemedicine Centre

GlobeNewswire July 14, 2020

DIAGNOS Announces that its Client in California, the Chaparral Medical Group of Clinics, is Reopening the Screening Services for Diabetic Retinopathy after the COVID-19 Shutdown

GlobeNewswire July 7, 2020

DIAGNOS Provides Update on its CARA AI Application Participating in US White House Call to Action Data Analysis Program

GlobeNewswire April 27, 2020

DIAGNOS Announces Stock Options Grant

GlobeNewswire March 27, 2020

DIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the "US White House - Call to Action" to Analyse and Transform COVID-19 Data into Clinical Knowledge

GlobeNewswire March 25, 2020

DIAGNOS Announces Closing of Oversubscribed $2.1 Million Private Placement

GlobeNewswire March 9, 2020

DIAGNOS Announces Private Placement of Common Shares

GlobeNewswire February 24, 2020

DIAGNOS Announces Shares for Debt Transaction

GlobeNewswire February 14, 2020

DIAGNOS Announces Closing of Private Placement

GlobeNewswire February 11, 2020

DIAGNOS Announces Private Placement of Common Shares

GlobeNewswire February 5, 2020

DIAGNOS Successfully Completes ISO 13485 / MDSAP Surveillance Audit

GlobeNewswire January 14, 2020

DIAGNOS AI based clinical Eye Test for Diabetic Retinopathy Demonstrates Exceptional Performance at the CHUM, expands for an Additional Six Months

GlobeNewswire January 7, 2020

DIAGNOS Announces a New Strategic Partnership Agreement in Costa Rica

GlobeNewswire December 12, 2019

DIAGNOS Announces Collaborative Agreement in the North American Borderplex Region

GlobeNewswire December 10, 2019

DIAGNOS Welcomes Mr. Francis Bellido to its Board of Directors

GlobeNewswire November 28, 2019

DIAGNOS Announces Short Term Financing

GlobeNewswire November 26, 2019